Acadia Pharmaceuticals
Sergio J. Davila, Ph.D. is a seasoned professional with a diverse background in various prestigious companies and educational institutions. With expertise in business development, strategy, and life sciences, Sergio has been actively involved in identifying and evaluating opportunities to expand portfolios, advising investors in the biotech, pharmaceutical, and medical device industries, and gaining extensive research experience in microbiology, immunobiology, and molecular biology. Sergio has also showcased exceptional leadership skills through their roles as President of the Harvard Biotechnology Club and as a Committee Member in the Massachusetts Life Sciences Initiative. Through their academic achievements from top institutions like Harvard University, Harvard Business School, and UCLA, Sergio has proven himself to be a valuable asset in the fields of business and life sciences.
This person is not in any teams
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.